3Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum, 1982, 25 ( 11 ):1271.
4Bombardier C, Gladman D D, Urowitz M B,et al. The committee on prognosis studies in SLE[J]. Arthritis Rheum,1992 ,35(6) :630.
5Stoll T, Gordon C, Seifert B, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36[J]. J Rheumatol, 1997,24(8):1608.
6Abu-shakra M, Mader R, Langevitz P, et al. Quality of life in systemic lupus erythematosus: a controlled study[J]. J Rheumatol, 1999 , 26 (2): 306.
7Cauda R,Tying SK,Grossi CE,et al.Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activity[J].J Clin Immunol,1987,7:304-307.
8Zhou J,Mcindoe A,Davis H,et al.The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expression human papillamavirus type 16L1[J].Virology,1991,181:203-210.
